KURA

Kura OncologyA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

KURA vs peer average

77/100

KURA vs. peer average (A vs. C)

Grade spread

A 1 · B 4 · C 1 · D 3

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

ABUS is the first available peer comparator.

Same-sector small-cap biotech with comparable market-cap risk dynamics; a loose comp for financing and binary-event sensitivity rather than direct product overlap.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerABUSArbutus Biopharma

KURA

Kura Oncology

ABUS

Arbutus Biopharma

Grade

Momentum

Value

Sentiment

100

Setup Bias

Net Neutral

Market Cap

Posture

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs ABUS

KURA / ABUS

Grade Position

Above peers

KURA vs. peer average (A vs. C)

77/100

Momentum

KURA

Value

KURA

Sentiment

100

KURA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs KURA

80/100

40/100

80/100

LB Pharmaceuticals Inc Common

N/A

EVMN

Evommune Inc Common

N/A

ABUS is the first peer returned for this comparison set.